Five human monoclonal antibodies isolated from hMPV-infected children demonstrated neutralizing potency and protected against hMPV challenge in mice.
The isolation and structural characterization of five neutralizing mAbs from hMPV-infected children reveal new immunodominant epitopes, including intratrimer sites, providing novel targets for hMPV disease prevention.
Absolute Event Rate: 0% vs 0%
Human metapneumovirus (hMPV) is a significant cause of acute respiratory illness in children and older adults, with most children becoming seropositive by five years of age. The hMPV fusion (F) protein is the sole target of neutralizing antibodies, and while most common B-cell-targeted neutralizing epitopes on the hMPV F protein have been determined in hMPV-infected adults, the antibody response in hMPV-infected children remains undefined. We isolate five human monoclonal antibodies (mAbs) from hMPV-infected children, and evaluate their binding avidity, neutralization potency, epitope specificity, and in vivo efficacy. All mAbs are neutralizing, and epitope binning reveals four different epitopes targeted by the mAbs. Cryo-EM structures of four mAbs in complex with the hMPV F protein reveal epitopes on the hMPV F trimer surface as well as an intratrimer epitope located completely within the hMPV F trimer interface. Furthermore, we determine the prophylactic efficacy of the mAbs in protection against hMPV challenge in mice. These findings provide new insights into the immunodominant antigenic epitopes on the hMPV F protein in children and identify new mAbs for hMPV F disease prevention.
Khalil et al. (Sat,) reported a other. Five human monoclonal antibodies isolated from hMPV-infected children demonstrated neutralizing potency and protected against hMPV challenge in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: